Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Vol. 232, No. 6, 2016

Issue release date: April 2017

Add all to MyReading List
Review Paper

Psoriasis and Obesity

Jensen P. · Skov L.
Dermatology 2016;232:633-639 (DOI:10.1159/000455840)
link -Key Message: Psoriasis is associated with obesity, and therefore nutritional care should be part of the management of psoriasis.
Free Access
Original Paper

Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT

Maul J.-T. · Djamei V. · Kolios A.G.A. · Meier B. · Czernielewski J. · Jungo P. · Yawalkar N. · Mainetti C. · Laffitte E. · Spehr C. · Anliker M. · Streit M. · Augustin M. · Rustenbach S. · Conrad C. · Hafner J. · Boehncke W.-H. · Borradori L. · Gilliet M. · Itin P. · French L.E. · Häusermann P. · Navarini A.A.
Dermatology 2016;232:640-647 (DOI:10.1159/000452740)
link -Key Message: Current therapeutic targets of PASI75 were reached in only 58% in this real-world setting.
-Free Supplementary Material
Free Access

Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients

Talamonti M. · Galluzzo M. · Servoli S. · D'Adamio S. · Bianchi L.
Dermatology 2016;232:648-654 (DOI:10.1159/000453661)
link -Key Message: The assessment of alexithymia should be a part of the comprehensive care of psoriasis patients.
-Free Supplementary Material
Free Access
IDEOM - Original Paper

Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry

Jungo P. · Maul J.-T. · Djamei V. · von Felten S. · Kolios A.G.A. · Czernielewsk J. · Yawalkar N. · Odermatt O. · Laffitte E. · Anliker M. · Streit M. · Augustin M. · Conrad C. · Hafner J. · Boehncke W.-H. · Gilliet M. · Itin P. · French L.E. · Navarini A.A. · Häusermann P.
Dermatology 2016;232:655-663 (DOI:10.1159/000455042)
link -Key Message: Biologics improve the subjective disease activity more than conventional systemic drugs as shown in a Swiss real-life psoriasis registry.
-Free Supplementary Material
Free Access
Original Paper

Impaired Pulmonary Function in Patients with Psoriasis

Balci D.D. · Celik E. · Genc S. · Çelik M.M. · Inan M.U.
Dermatology 2016;232:664-667 (DOI:10.1159/000456032)
link -Key Message: Psoriasis patients demonstrate impaired pulmonary function compared with control subjects.
-Free Supplementary Material
Free Access
Tattoo and Body Art - Original Paper

Classification of Tattoo Complications in a Hospital Material of 493 Adverse Events

Serup J. · Sepehri M. · Hutton Carlsen K.
Dermatology 2016;232:668-678 (DOI:10.1159/000452148)
link Key Message: Classification of tattoo complications seen in the hospital material of 493 adverse events.
Free Supplementary Material
Free Access

Papulo-Nodular Reactions in Black Tattoos as Markers of Sarcoidosis: Study of 92 Tattoo Reactions from a Hospital Material

Sepehri M. · Hutton Carlsen K. · Serup J.
Dermatology 2016;232:679-686 (DOI:10.1159/000453315)
link -Key Message: Black tattoos with papulo-nodular reactions should be seen as markers of sarcoidosis involving other organs.
-Free Supplementary Material
Free Access
Original Paper

Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa

Kouris A. · Platsidaki E. · Christodoulou C. · Efstathiou V. · Dessinioti C. · Tzanetakou V. · Korkoliakou P. · Zisimou C. · Antoniou C. · Kontochristopoulos G.
Dermatology 2016;232:687-691 (DOI:10.1159/000453355)
link Key Message: Hidradenitis suppurativa is a long-term skin disease associated with high levels of psychological distress and significant life impact.
Free Supplementary Material
Free Access

Factors Contributing to Depression and Chronic Pain in Patients with Hidradenitis Suppurativa: Results from a Single-Center Retrospective Review

Vangipuram R. · Vaidya T. · Jandarov R. · Alikhan A.
Dermatology 2016;232:692-695 (DOI:10.1159/000453259)
link -Key Message: The extent of disease, rather than its severity, is more significant in causing distress to patients with hidradenitis suppurativa.
-Free Supplementary Material
Free Access

Early Detection of Desiccation and Curettage Failure in the Treatment of Basal Cell Carcinoma

Woldow A.B. · Melvin M.E.
Dermatology 2016;232:696-699 (DOI:10.1159/000452884)
link Key Message: This is a novel method of deterring BCC treatment success by submitting curettage fragments for histological examination.
Free Supplementary Material
Free Access
Skin Cancer - Original Paper

Cutaneous Neoplasms in Myotonic Dystrophy Type 1

Marcoval J. · Olivé M. · Bonfill-Ortí M. · Martínez-Molina L. · Talavera-Belmonte A.
Dermatology 2016;232:700-703 (DOI:10.1159/000456074)
link -Key Message: Myotonic dystrophy predisposes to the development of basal cell carcinomas at a young age.
-Free Supplementary Material
Free Access

Unknown Primary Melanoma: Worldwide Survey on Clinical Management

Ribero S. · Pampena R. · Bataille V. · Moscarella E. · Thomas L. · Quaglino P. · Potenza C. · Van Akkooi A.C.J. · Testori A. · Nathan P. · Puig S. · Zalaudek I. · Argenziano G. · Longo C.
Dermatology 2016;232:704-707 (DOI:10.1159/000453592)
link Key Message: The management of unknown primary melanoma is highly heterogeneous; thus, a consensus document is needed.
Free Supplementary Material
Free Access

Comparison of “Lesion-by-Lesion” and Field Photodynamic Therapy in the Prevention of Actinic Keratoses: A Randomized, Split-Face, Single-Blind Pilot Study

Seubring I. · Groenewoud J.M.M. · Gerritsen M.-J.P.
Dermatology 2016;232:708-714 (DOI:10.1159/000453610)
link -Key Message: In-patient comparison of “lesion-by-lesion” and “field” MAL-PDT (methyl aminolevulinate photodynamic therapy) demonstrates the superiority of field MAL-PDT with respect to the prevention of actinic keratoses.
-Free Supplementary Material
Open Access Gateway
Original Paper

What Is the Key to Improving Renal Transplant Recipients' Awareness of Skin Cancer Risk?

Borghi A. · Corazza M. · Battaglia Y. · Maietti E. · Minghetti S. · Virgili A.
Dermatology 2016;232:715-720 (DOI:10.1159/000458756)
link -Key Message: Improving the way education is delivered to transplant recipients may increase their awareness of skin cancer risk.
-Free Supplementary Material
Free Access
Skin Cancer - Original Paper

Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients

Dereure O. · Missan H. · Girard C. · Costes V. · Guillot B.
Dermatology 2016;232:721-730 (DOI:10.1159/000461578)
link -Key Message: Cetuximab alone or with chemotherapy may control locally advanced or metastatic cutaneous squamous cell carcinoma.
-Free Supplementary Material
Free Access

Risk Factors for Skin Infections in Mycosis Fungoides

Lebas E. · Arrese J.E. · Nikkels A.F.
Dermatology 2016;232:731-737 (DOI:10.1159/000455944)
link -Key Message: Late-stage mycosis fungoides patients with extended lesions should be closely monitored for cutaneous (viral, bacterial, or fungal) infections.
-Free Supplementary Material
Free Access
Original Paper

Characterization of Cutaneous Plasmacytosis at Different Disease Stages

Hsiao P.-F. · Wu Y.-H.
Dermatology 2016;232:738-747 (DOI:10.1159/000456073)
link -Key Message: This study characterizes the features of cutaneous plasmacytosis at different stages of the disease.
-Free Supplementary Material
Free Access
Basic Science Investigations

Luminex LiquiChip System for the Evaluation of Cytokine Levels in Patients with Contact Dermatitis to Potassium Dichromate

Akerman L. · Klein T. · Israeli M. · Fraser A. · Sagy E. · Snast I. · Mimouni D. · David M. · Trattner A.
Dermatology 2016;232:748-751 (DOI:10.1159/000456031)
link -Key Message: The Luminex LiquiChip is a promising in vitro method for the diagnosis of allergic contact dermatitis.
-Free Supplementary Material
Free Access
Original Paper

Clinical Presentation of Cutaneous Leishmaniasis caused by Leishmania major

Remadi L. · Haouas N. · Chaara D. · Slama D. · Chargui N. · Dabghi R. · Jbeniani H. · Mezhoud H. · Babba H.
Dermatology 2016;232:752-759 (DOI:10.1159/000456543)
link -Key Message: This article presents an overview of the clinical polymorphism of cutaneous leishmaniasis caused by Leishmania major in Tunisia.
Free Supplementary Material
Free Access

Acknowledgement to Referees for Dermatology 2016

Dermatology 2016;232:760-761 (DOI:10.1159/000475488)
Free Access

Contents Vol. 232, 2016

Dermatology 2016;232:I-X (DOI:10.1159/000475489)
Free Access